MAPT and Alzheimer disease: We then examined the effects of VBIT-4 on other proteins implicated in AD pathology and found that the level of p-Tau was increased (2.7-fold) in 5 × FAD, but VBIT-4 treatment had no effect on its level (Fig. 4e, f).